Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 328

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 3
Chunk 328
---
ars and adjusted scripts in millions)2025202420252024Total adjusted revenuesPharmacy Benefit Services$31,954 $26,630 20 %$61,696 $52,737 17 %Specialty and Care Services25,871 22,918 13 49,810 43,037 16 Total adjusted revenues$57,825 $49,548 17 %$111,506 $95,774 16 %Pre-tax adjusted income from operationsPharmacy Benefit Services$833 $816 2 %$1,377 $1,341 3 %Specialty and Care Services863 803 7 1,753 1,638 7 Total pre-tax adjusted income from operations$1,696 $1,619 5 %$3,130 $2,979 5 %Pharmacy claim volume (1)548 533 3 %1,087 1,046 4 %

(1)Non-specialty network prescriptions filled through 90-day programs and home delivery prescriptions are counted as three claims. All other network and specialty prescriptions are counted as one claim.

41

Three and Six Months Ended June 30, 2025 versus Three and Six Months Ended June 30, 2024

Commentary in parentheses regarding percentage changes represents the driver's impact on the overall category.

Adjusted revenues increased 17% and 16% for the three and six months ended, respectively, primarily reflecting higher utilization of prescription drugs from customer growth in Pharmacy Benefit Services (+7% and +7%, respectively) and Specialty and Care Services (+6% and +7%, respectively) and an increase due to claims composition in Pharmacy Benefit Services (+4% and +2%, respectively). 

Pre-tax adjusted income from operations increased 5% and 5% for the three and six months ended, respectively, primarily reflecting specialty pharmacy growth in Specialty and Care Services (+8% and +6%, respectively), and contract affordability improvements and customer growth in Pharmacy Benefit Services (+3% and +3%, respectively), partially offset by strategic investments and initiatives to support business growth in Specialty and Care Services (-3% and -2%, respectively) and Pharmacy Benefit Services (-1% and -2%, respectively).

The SG&A expense ratio decreased 10 bps for both the three and six months ended, primarily reflecting higher adjusted revenues as discussed above.

Cigna Healthcare Segment

Cigna Healthcare includes the U